|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial 显示文摘 | Thadhani R Appelbaum E Pritchett Y | 2012 | JAMA2012，307，7： | 1 |
| 2 | Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease:the PRIMO randomized controlled trial 显示文摘 | Thadhani R Appelbaum E Pritchett Y | 2012 | JAMA2012，307，7： | 1 |
| 3 | Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy 显示文摘 | Kohan D E Pritchett Y Molitch M | 2011 | J Am Soc Nephrol2011，22，4： | 1 |
| 4 | The safe- ty and tolerability of duloxetine compared with paroxetine and placebo : a pooled analysis of 4 clinicahrials 显示文摘 | Nelson J C Lu Pritchett Y Martynov 0 | 2006 | Prim Care Companion J Clin Psychiatry2006，8，4： | 1 |
| 5 | Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial 显示文摘 | Thadhani R Appelbaum E Pritchett Y | 2012 | JAMA2012，307，7： | 1 |
| 6 | Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy显示文摘 | Kohan DE Pritchett Y Molitch M | 2011 | J Am Soc Nephrol2011，22，4： | 1 |
| 7 | Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease:the PRIMO randomized controlled trial显示文摘 | Thadhani R Appelbaum E Pritchett Y | 2012 | JAMA2012，307，7： | 1 |
| 8 | Duloxetine for patients with diabetic peripheral neuropathic pain:a 6-month open-label safety study显示文摘 | RASKIN J WANG F PRITCHETT Y L | 2006 | Pain Med2006，7，5： | 1 |
| 9 | A ran-domized,double-blind,placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder显示文摘 | ARNOLD L M ROSEN A PRITCHETT Y L | 2005 | Pain2005，119，13： | 1 |
| 10 | Linear Analysis of the Double-Tearing Mode显示文摘 | Pritchett P L Lee Y C Drake J F | 1980 | Physics of Fluids1980，23，7： | 1 |
| 11 | A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic perperal neuropathic pain 显示文摘 | Raskin J Pritchett Y L Wang F | 2005 | Pain Med2005，6，5： | 1 |
| 12 | Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in dia- betic nephropathy显示文摘 | Kohan D E Pritchett Y Molitch M | 2011 | J Am Soc Nephrol2011，22，4： | 1 |
| 13 | A randomized, dou- ble - blind Comparison of duloxetine and venlafaxine in the treat- ment of patients with major depression disorder显示文摘 | Perahia D G Pritchett Y L Kajdasz D K | 2008 | J Psychiatr Res2008，42，1： | 1 |
| 14 | Addition of atrasentan to renin-angiotensin system blockade reducesalbuminuria in diabetic nephropathy 显示文摘 | Kohan DE Pritchett Y Molitch M | 2011 | J Am Soc Nephrol2011，22，4： | 1 |
| 15 | Addition of atrasentan to renin- angiotensin system blockade reduces albuminuria in diabetic nephrepa- thy显示文摘 | Kohan DE Pritchett Y Molitch M | 2011 | J Am Soc Nephrel2011，22，4： | 1 |
| 16 | Efficacy of duloxetine in painful symptoms:an analgesic or antidepressant effect显示文摘 | Perahia D G Pritchett Y L Desaiah D | | 0，，06： | 1 |
| 17 | Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease(CKD) 显示文摘 | Andress DL Coil B Pritchett Y | 2012 | Life Sci2012，91，1314： | 1 |
| 18 | One-photon photophysics and two-photon absorption of 4--2,2':6',2″-terpyridine and their platinum chloride complexes显示文摘 | Ji Z Li Y Pritchett T M | 2011 | Chemistry-A European Journal2011，17，8： | 1 |
| 19 | Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in dia- betic nephropathy 显示文摘 | Kohan D E Pritchett Y Molitch M | 2011 | J Am Soc Nephrol2011，22，4： | 1 |
| 20 | The clinical importance of changes in die 0 to 10 numeric rating scale for worst, least, and average pain intensity: Analyses of data from clinical trials of duloxetine in pain disorders 显示文摘 | Farrar J T Pritchett Y L Robinson M | 2010 | J Pain2010，11，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员